Elsa Kress will represent Antineo at the Meet2Win Convention in Oncology in Bordeaux, France, May 21st and 22nd. Please don’t hesitate to contact us for a meeting! You can fill the form below and we will get back you.
Morgane joined us on December 2018 as our new PhD candidate. She did her Matser Thesis at Antineo in 2017, and worked for a year as a Study Manager at the Lyon Sud hospital. She will be working on developing […]
Check out the new Information Sheets for our CDX preclinical tumour models of Multiple Myeloma (MM)!
Elsa Kress will represent Antineo at the Forum CLARA in Lyon, on April 4th and 5th 2019. Please don’t hesitate to contact us for a meeting! You can fill the form below and we will get back you.
Now online, the Information Sheets for our NHL CDX models, including Follicular Lymphoma, Mantle Cells Lymphoma, Diffuse Large B-Cells Lymphoma and Burkitt’s Lymphoma.
Elsa Kress will be present at the Key advances and future promises in immunotherapy antibodies and cellular therapies for the treatment of cancers and inflammatory diseases, in Montpellier on March 28th 2019. Do not hesitate to contact us to discuss […]
Now online, the Information Sheets for our Acute Myeloid Leukemia CDX models!
The team Antineo whishes you a year 2019 full of success and new projects!
Repositive – the creator of the proprietary platform that enables oncology researchers to search for the pre-clinical cancer models and services they need to drive research, from a list of multiple global Contract Research Organisations (CROs) – has announced that […]
Check out the new Information Sheets for our CDX preclinical tumour models of Acute Lymphoblastoid Leukemia (ALL)!